# US 2022/0024990 A1 · Species of tobamovirus

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0024990 A1
- Document ID: US20220024990A1
- Status: Published application
- Kind: A1
- Application number: 17/409,283
- Filed: 2021-08-23
- Published: 2022-01-27
- Earliest claimed: 2015-07-17
- Assignees: Nunhems B.V.
- Applicants: Nunhems B.V.
- Inventors: Bart Peter Johan GERAATS; Marco Antonio MAMMELLA; Massimo TURINA; Marina CIUFFO
- Web page: https://patentgrep.com/patent/US20220024990A1

## CPC

- C07K 14/005: from viruses
- C07K 16/10: RNA viruses
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C12Q 1/701: {Specific hybridization probes}
- G01N 33/5097: {involving plant cells (immunoassays of plant cells G01N33/56961)}
- C12N 2770/00021: Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2770/00022: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2770/00031: Uses of virus other than therapeutic or vaccine, e.g. disinfectant
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides a new species of tobamovirus and its use to identify plants comprising resistance against the virus.

## Claims

### Claim 1

(canceled)

### Claim 2

(canceled)

### Claim 3

(canceled)

### Claim 4

(canceled)

### Claim 5

A sterilized solution comprising a tobamovirus whose genome comprises at least 95% sequence identity to SEQ ID NO: 1, wherein the virus causes systemic symptoms on Solanum lycopersicum plants homozygous for one or more Tm resistance genes of Tm1, Tm2, and/or Tm22.

### Claim 6

(canceled)

### Claim 7

(canceled)

### Claim 8

(canceled)

### Claim 9

(canceled)

### Claim 10

(canceled)

### Claim 11

(canceled)

### Claim 12

(canceled)

### Claim 13

(canceled)

### Claim 14

(canceled)

### Claim 15

(canceled)

### Claim 16

(canceled)

### Claim 17

A protein selected from the group consisting of: a protein comprising at least 93% sequence identity to SEQ ID NO: 3, a protein comprising at least 94% sequence identity to SEQ ID NO: 4, a protein, comprising at least 80% sequence identity to SEQ ID NO: 5 and a protein, or of a nucleic acid sequence encoding a protein, comprising at least 82% sequence identity to SEQ ID NO: 6.

### Claim 18

An antibody raised against a protein or protein part selected from the group consisting of: a protein comprising at least 93% sequence identity to SEQ ID NO: 3, a protein comprising at least 94% sequence identity to SEQ ID NO: 4, a protein, comprising at least 80% sequence identity to SEQ ID NO: 5 and a protein, or of a nucleic acid sequence encoding a protein, comprising at least 82% sequence identity to SEQ ID NO: 6.

### Claim 19 (depends on 5)

The sterilized solution of claim 5, wherein the virus causes systemic symptoms on Solanum lycopersicum plants homozygous for Tm22.

### Claim 20 (depends on 5)

The sterilized solution of claim 5, wherein the virus causes systemic symptoms on Solanum lycopersicum plants homozygous for Tm1, Tm2, and Tm22.

### Claim 21 (depends on 5)

The sterilized solution of claim 5, wherein the tobamovirus genome comprises at least 97% sequence identity to SEQ ID NO: 1.

### Claim 22 (depends on 5)

The sterilized solution of claim 5, wherein the tobamovirus genome comprises at least 99% sequence identity to SEQ ID NO: 1.

### Claim 23 (depends on 5)

The sterilized solution of claim 5, wherein the tobamovirus genome comprises SEQ ID NO: 1.

### Claim 24 (depends on 5)

The sterilized solution of claim 5, wherein the sterilized solution comprises a buffer.
